Literature DB >> 20833543

Synthesis and biological evaluation of novel triptolide analogues for anticancer activity.

Bing Zhou1, Zehong Miao, Gang Deng, Jian Ding, Yaxi Yang, Huijin Feng, Yuanchao Li.   

Abstract

Three types of novel triptolide analogues with 9,11-olefin (3-5), five-membered unsaturated lactam ring (6-7) or A/B cis ring junction (8-14) were synthesized. Although with 9,11-olefin instead of 9,11-β-epoxide, compound 4a was much more active than the parent natural triptolide (1) with the lowest IC(50) value of 0.05nM for SKOV-3 cells, clearly challenging the traditional viewpoint on the necessity of 9,11-β-epoxide group of triptolide. In addition, structure-activity relationships for three classes of compounds were studied.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833543     DOI: 10.1016/j.bmcl.2010.08.106

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Synthesis of (-)-Mitrephorone A via a Bioinspired Late Stage C-H Oxidation of (-)-Mitrephorone B.

Authors:  Lukas Anton Wein; Klaus Wurst; Peter Angyal; Lara Weisheit; Thomas Magauer
Journal:  J Am Chem Soc       Date:  2019-12-03       Impact factor: 15.419

2.  Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B.

Authors:  Lu Wen; Yan Chen; Ling-lan Zeng; Fei Zhao; Rui Li; Yuan Liu; Chun Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-11-28       Impact factor: 6.150

3.  Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide.

Authors:  Qing-Li He; Denis V Titov; Jing Li; Minjia Tan; Zhaohui Ye; Yingming Zhao; Daniel Romo; Jun O Liu
Journal:  Angew Chem Int Ed Engl       Date:  2014-12-12       Impact factor: 15.336

4.  Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.

Authors:  Yuli Lin; Nana Peng; Jianping Li; Hongqin Zhuang; Zi-Chun Hua
Journal:  Mol Cancer       Date:  2013-06-08       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.